🇬🇧 From market access to the evaluation of AI-based medical devices: a regulatory adventure

Nov 16, 2022 | 10:40 AM CET - 11:05 AM CET

Presented By

Marion Abecassis

Attorney in Life Sciences

Aurélie Bajon

Head of QARA

Eleonora Harwich

Director and member of the British Standards Institution’s Committee on Artificial Intelligence

Jérôme Fabiano

Public Affairs Director

Jean Dietzel

Novartis BIOME Germany Lead

Teaser Sessions

10:25 am - 10:40 am

Startups Masterclass Stage

🇬🇧 New AI solutions for improved cancer diagnosis and optimized treatment

The latest advances in AI revolutionized the field of histopathology. Tribun Health, a computational pathology pioneer, empowers pathology labs and pharma sponsors with...

AI & Computer Vision Director

12:00 pm - 12:10 pm

Startups Masterclass Stage

🇫🇷 Construire le futur de la psychiatrie de précision dans le parcours de soin de pathologies...

Current approaches to the detection, diagnosis and monitoring of psychiatric disorders rely heavily on the experience of the psychiatrist and on physician-patient...

Yannick Trescos

ResilEyes Therapeutics

CEO & Co-founder

9:55 am - 10:05 am

🇬🇧 Real World Evidence to Inform Health Decisions : Data and Methodological Considerations for...

VP Analytics And Insight RWE

12:25 pm - 12:45 pm

Corporate Masterclass Stage

🇫🇷 Intelligence artificielle dans les hôpitaux : du développement au déploiement

The hype around AI is stirring up the healthcare world and piquing our interest. We therefore conducted a survey of AI use cases in French hospitals, allowing us to...

Pr Jean-Marc Bereder

Centre Hospitalier Universitaire de Nice

Artificial Intelligence in Health Project Manager